等待開盤 09-20 09:30:00 美东时间
0.000
0.00%
Maintaining robust financial runway after the prepayment Reinforcing Ainos' com...
08-06 19:30
Ainos, Inc. (NASDAQ:AIMD, AIMDW)))) ("Ainos," or the "Company"), a diversified healthcare company focused on the development of AI-powered point-of-care testing, VELDONA® low-dose interferon therapeutics, and
2023-12-12 21:03
Proceeds to fund company's clinical trials, commercial product launch, and working capitalInitial conversion price set at $1.50 per shareSAN DIEGO, CA / ACCESSWIRE / September 25, 2023 / Ainos, Inc. (NASDAQ:AIMD,
2023-09-25 20:33